{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1362825896030697472.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1161/circresaha.115.306874"}},{"identifier":{"@type":"URI","@value":"https://www.ahajournals.org/doi/full/10.1161/CIRCRESAHA.115.306874"}}],"dc:title":[{"@value":"Bioengineering Human Myocardium on Native Extracellular Matrix"}],"description":[{"type":"abstract","notation":[{"@value":"<jats:sec>\n            <jats:title>\n              <jats:underline>Rationale:</jats:underline>\n            </jats:title>\n            <jats:p>More than 25 million individuals have heart failure worldwide, with ≈4000 patients currently awaiting heart transplantation in the United States. Donor organ shortage and allograft rejection remain major limitations with only ≈2500 hearts transplanted each year. As a theoretical alternative to allotransplantation, patient-derived bioartificial myocardium could provide functional support and ultimately impact the treatment of heart failure.</jats:p>\n          </jats:sec>\n          <jats:sec>\n            <jats:title>\n              <jats:underline>Objective:</jats:underline>\n            </jats:title>\n            <jats:p>The objective of this study is to translate previous work to human scale and clinically relevant cells for the bioengineering of functional myocardial tissue based on the combination of human cardiac matrix and human induced pluripotent stem cell–derived cardiomyocytes.</jats:p>\n          </jats:sec>\n          <jats:sec>\n            <jats:title>\n              <jats:underline>Methods and Results:</jats:underline>\n            </jats:title>\n            <jats:p>To provide a clinically relevant tissue scaffold, we translated perfusion-decellularization to human scale and obtained biocompatible human acellular cardiac scaffolds with preserved extracellular matrix composition, architecture, and perfusable coronary vasculature. We then repopulated this native human cardiac matrix with cardiomyocytes derived from nontransgenic human induced pluripotent stem cells and generated tissues of increasing 3-dimensional complexity. We maintained such cardiac tissue constructs in culture for 120 days to demonstrate definitive sarcomeric structure, cell and matrix deformation, contractile force, and electrical conduction. To show that functional myocardial tissue of human scale can be built on this platform, we then partially recellularized human whole-heart scaffolds with human induced pluripotent stem cell–derived cardiomyocytes. Under biomimetic culture, the seeded constructs developed force-generating human myocardial tissue and showed electrical conductivity, left ventricular pressure development, and metabolic function.</jats:p>\n          </jats:sec>\n          <jats:sec>\n            <jats:title>\n              <jats:underline>Conclusions:</jats:underline>\n            </jats:title>\n            <jats:p>Native cardiac extracellular matrix scaffolds maintain matrix components and structure to support the seeding and engraftment of human induced pluripotent stem cell–derived cardiomyocytes and enable the bioengineering of functional human myocardial-like tissue of multiple complexities.</jats:p>\n          </jats:sec>"}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1382825896030697475","@type":"Researcher","foaf:name":[{"@value":"Jacques P. Guyette"}],"jpcoar:affiliationName":[{"@value":"From the Center for Regenerative Medicine (J.P.G., J.M.C., B.J.J., P.T.M., S.E.G., T.O., G.G., H.C.O.), Cardiovascular Research Center (R.W.M., D.J.M.), Division of Cardiology (D.J.M.), and Division of Thoracic Surgery, Department of Surgery (H.C.O.), Massachusetts General Hospital, Boston, MA; Harvard Medical School, Boston, MA (J.P.G., B.J.J., P.T.M., S.E.G., G.G., H.C.O.); Department of Biomedical Engineering, Worcester Polytechnic Institute, Worcester, MA (J.R.G., G.R.G.); and Harvard Stem Cell..."}]},{"@id":"https://cir.nii.ac.jp/crid/1382825896030697349","@type":"Researcher","foaf:name":[{"@value":"Jonathan M. Charest"}],"jpcoar:affiliationName":[{"@value":"From the Center for Regenerative Medicine (J.P.G., J.M.C., B.J.J., P.T.M., S.E.G., T.O., G.G., H.C.O.), Cardiovascular Research Center (R.W.M., D.J.M.), Division of Cardiology (D.J.M.), and Division of Thoracic Surgery, Department of Surgery (H.C.O.), Massachusetts General Hospital, Boston, MA; Harvard Medical School, Boston, MA (J.P.G., B.J.J., P.T.M., S.E.G., G.G., H.C.O.); Department of Biomedical Engineering, Worcester Polytechnic Institute, Worcester, MA (J.R.G., G.R.G.); and Harvard Stem Cell..."}]},{"@id":"https://cir.nii.ac.jp/crid/1382825896030697474","@type":"Researcher","foaf:name":[{"@value":"Robert W. Mills"}],"jpcoar:affiliationName":[{"@value":"From the Center for Regenerative Medicine (J.P.G., J.M.C., B.J.J., P.T.M., S.E.G., T.O., G.G., H.C.O.), Cardiovascular Research Center (R.W.M., D.J.M.), Division of Cardiology (D.J.M.), and Division of Thoracic Surgery, Department of Surgery (H.C.O.), Massachusetts General Hospital, Boston, MA; Harvard Medical School, Boston, MA (J.P.G., B.J.J., P.T.M., S.E.G., G.G., H.C.O.); Department of Biomedical Engineering, Worcester Polytechnic Institute, Worcester, MA (J.R.G., G.R.G.); and Harvard Stem Cell..."}]},{"@id":"https://cir.nii.ac.jp/crid/1382825896030697346","@type":"Researcher","foaf:name":[{"@value":"Bernhard J. Jank"}],"jpcoar:affiliationName":[{"@value":"From the Center for Regenerative Medicine (J.P.G., J.M.C., B.J.J., P.T.M., S.E.G., T.O., G.G., H.C.O.), Cardiovascular Research Center (R.W.M., D.J.M.), Division of Cardiology (D.J.M.), and Division of Thoracic Surgery, Department of Surgery (H.C.O.), Massachusetts General Hospital, Boston, MA; Harvard Medical School, Boston, MA (J.P.G., B.J.J., P.T.M., S.E.G., G.G., H.C.O.); Department of Biomedical Engineering, Worcester Polytechnic Institute, Worcester, MA (J.R.G., G.R.G.); and Harvard Stem Cell..."}]},{"@id":"https://cir.nii.ac.jp/crid/1382825896030697345","@type":"Researcher","foaf:name":[{"@value":"Philipp T. Moser"}],"jpcoar:affiliationName":[{"@value":"From the Center for Regenerative Medicine (J.P.G., J.M.C., B.J.J., P.T.M., S.E.G., T.O., G.G., H.C.O.), Cardiovascular Research Center (R.W.M., D.J.M.), Division of Cardiology (D.J.M.), and Division of Thoracic Surgery, Department of Surgery (H.C.O.), Massachusetts General Hospital, Boston, MA; Harvard Medical School, Boston, MA (J.P.G., B.J.J., P.T.M., S.E.G., G.G., H.C.O.); Department of Biomedical Engineering, Worcester Polytechnic Institute, Worcester, MA (J.R.G., G.R.G.); and Harvard Stem Cell..."}]},{"@id":"https://cir.nii.ac.jp/crid/1382825896030697344","@type":"Researcher","foaf:name":[{"@value":"Sarah E. Gilpin"}],"jpcoar:affiliationName":[{"@value":"From the Center for Regenerative Medicine (J.P.G., J.M.C., B.J.J., P.T.M., S.E.G., T.O., G.G., H.C.O.), Cardiovascular Research Center (R.W.M., D.J.M.), Division of Cardiology (D.J.M.), and Division of Thoracic Surgery, Department of Surgery (H.C.O.), Massachusetts General Hospital, Boston, MA; Harvard Medical School, Boston, MA (J.P.G., B.J.J., P.T.M., S.E.G., G.G., H.C.O.); Department of Biomedical Engineering, Worcester Polytechnic Institute, Worcester, MA (J.R.G., G.R.G.); and Harvard Stem Cell..."}]},{"@id":"https://cir.nii.ac.jp/crid/1382825896030697476","@type":"Researcher","foaf:name":[{"@value":"Joshua R. Gershlak"}],"jpcoar:affiliationName":[{"@value":"From the Center for Regenerative Medicine (J.P.G., J.M.C., B.J.J., P.T.M., S.E.G., T.O., G.G., H.C.O.), Cardiovascular Research Center (R.W.M., D.J.M.), Division of Cardiology (D.J.M.), and Division of Thoracic Surgery, Department of Surgery (H.C.O.), Massachusetts General Hospital, Boston, MA; Harvard Medical School, Boston, MA (J.P.G., B.J.J., P.T.M., S.E.G., G.G., H.C.O.); Department of Biomedical Engineering, Worcester Polytechnic Institute, Worcester, MA (J.R.G., G.R.G.); and Harvard Stem Cell..."}]},{"@id":"https://cir.nii.ac.jp/crid/1382825896030697348","@type":"Researcher","foaf:name":[{"@value":"Tatsuya Okamoto"}],"jpcoar:affiliationName":[{"@value":"From the Center for Regenerative Medicine (J.P.G., J.M.C., B.J.J., P.T.M., S.E.G., T.O., G.G., H.C.O.), Cardiovascular Research Center (R.W.M., D.J.M.), Division of Cardiology (D.J.M.), and Division of Thoracic Surgery, Department of Surgery (H.C.O.), Massachusetts General Hospital, Boston, MA; Harvard Medical School, Boston, MA (J.P.G., B.J.J., P.T.M., S.E.G., G.G., H.C.O.); Department of Biomedical Engineering, Worcester Polytechnic Institute, Worcester, MA (J.R.G., G.R.G.); and Harvard Stem Cell..."}]},{"@id":"https://cir.nii.ac.jp/crid/1382825896030697350","@type":"Researcher","foaf:name":[{"@value":"Gabriel Gonzalez"}],"jpcoar:affiliationName":[{"@value":"From the Center for Regenerative Medicine (J.P.G., J.M.C., B.J.J., P.T.M., S.E.G., T.O., G.G., H.C.O.), Cardiovascular Research Center (R.W.M., D.J.M.), Division of Cardiology (D.J.M.), and Division of Thoracic Surgery, Department of Surgery (H.C.O.), Massachusetts General Hospital, Boston, MA; Harvard Medical School, Boston, MA (J.P.G., B.J.J., P.T.M., S.E.G., G.G., H.C.O.); Department of Biomedical Engineering, Worcester Polytechnic Institute, Worcester, MA (J.R.G., G.R.G.); and Harvard Stem Cell..."}]},{"@id":"https://cir.nii.ac.jp/crid/1382825896030697473","@type":"Researcher","foaf:name":[{"@value":"David J. Milan"}],"jpcoar:affiliationName":[{"@value":"From the Center for Regenerative Medicine (J.P.G., J.M.C., B.J.J., P.T.M., S.E.G., T.O., G.G., H.C.O.), Cardiovascular Research Center (R.W.M., D.J.M.), Division of Cardiology (D.J.M.), and Division of Thoracic Surgery, Department of Surgery (H.C.O.), Massachusetts General Hospital, Boston, MA; Harvard Medical School, Boston, MA (J.P.G., B.J.J., P.T.M., S.E.G., G.G., H.C.O.); Department of Biomedical Engineering, Worcester Polytechnic Institute, Worcester, MA (J.R.G., G.R.G.); and Harvard Stem Cell..."}]},{"@id":"https://cir.nii.ac.jp/crid/1382825896030697472","@type":"Researcher","foaf:name":[{"@value":"Glenn R. Gaudette"}],"jpcoar:affiliationName":[{"@value":"From the Center for Regenerative Medicine (J.P.G., J.M.C., B.J.J., P.T.M., S.E.G., T.O., G.G., H.C.O.), Cardiovascular Research Center (R.W.M., D.J.M.), Division of Cardiology (D.J.M.), and Division of Thoracic Surgery, Department of Surgery (H.C.O.), Massachusetts General Hospital, Boston, MA; Harvard Medical School, Boston, MA (J.P.G., B.J.J., P.T.M., S.E.G., G.G., H.C.O.); Department of Biomedical Engineering, Worcester Polytechnic Institute, Worcester, MA (J.R.G., G.R.G.); and Harvard Stem Cell..."}]},{"@id":"https://cir.nii.ac.jp/crid/1382825896030697347","@type":"Researcher","foaf:name":[{"@value":"Harald C. Ott"}],"jpcoar:affiliationName":[{"@value":"From the Center for Regenerative Medicine (J.P.G., J.M.C., B.J.J., P.T.M., S.E.G., T.O., G.G., H.C.O.), Cardiovascular Research Center (R.W.M., D.J.M.), Division of Cardiology (D.J.M.), and Division of Thoracic Surgery, Department of Surgery (H.C.O.), Massachusetts General Hospital, Boston, MA; Harvard Medical School, Boston, MA (J.P.G., B.J.J., P.T.M., S.E.G., G.G., H.C.O.); Department of Biomedical Engineering, Worcester Polytechnic Institute, Worcester, MA (J.R.G., G.R.G.); and Harvard Stem Cell..."}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00097330"},{"@type":"EISSN","@value":"15244571"}],"prism:publicationName":[{"@value":"Circulation Research"}],"dc:publisher":[{"@value":"Ovid Technologies (Wolters Kluwer Health)"}],"prism:publicationDate":"2016-01-08","prism:volume":"118","prism:number":"1","prism:startingPage":"56","prism:endingPage":"72"},"reviewed":"false","url":[{"@id":"https://www.ahajournals.org/doi/full/10.1161/CIRCRESAHA.115.306874"}],"createdAt":"2015-10-27","modifiedAt":"2024-05-13","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360565165972999168","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Challenges to success in heart failure: Cardiac cell therapies in patients with heart diseases"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001288148807168","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Regenerative Therapy for Patients with Congenital Heart          Disease"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1161/circresaha.115.306874"},{"@type":"CROSSREF","@value":"10.1016/j.jjcc.2016.04.010_references_DOI_FnKfpNsgPSVA9SC6dC2mXA5tK8j"},{"@type":"CROSSREF","@value":"10.2302/kjm.2018-0002-ir_references_DOI_FnKfpNsgPSVA9SC6dC2mXA5tK8j"}]}